Cargando…
Development of a Urine Metabolomics Biomarker-Based Prediction Model for Preeclampsia during Early Pregnancy
Preeclampsia (PE) is a condition that poses a significant risk of maternal mortality and multiple organ failure during pregnancy. Early prediction of PE can enable timely surveillance and interventions, such as low-dose aspirin administration. In this study, conducted at Stanford Health Care, we exa...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301596/ https://www.ncbi.nlm.nih.gov/pubmed/37367874 http://dx.doi.org/10.3390/metabo13060715 |
_version_ | 1785064849763467264 |
---|---|
author | Zhang, Yaqi Sylvester, Karl G. Jin, Bo Wong, Ronald J. Schilling, James Chou, C. James Han, Zhi Luo, Ruben Y. Tian, Lu Ladella, Subhashini Mo, Lihong Marić, Ivana Blumenfeld, Yair J. Darmstadt, Gary L. Shaw, Gary M. Stevenson, David K. Whitin, John C. Cohen, Harvey J. McElhinney, Doff B. Ling, Xuefeng B. |
author_facet | Zhang, Yaqi Sylvester, Karl G. Jin, Bo Wong, Ronald J. Schilling, James Chou, C. James Han, Zhi Luo, Ruben Y. Tian, Lu Ladella, Subhashini Mo, Lihong Marić, Ivana Blumenfeld, Yair J. Darmstadt, Gary L. Shaw, Gary M. Stevenson, David K. Whitin, John C. Cohen, Harvey J. McElhinney, Doff B. Ling, Xuefeng B. |
author_sort | Zhang, Yaqi |
collection | PubMed |
description | Preeclampsia (PE) is a condition that poses a significant risk of maternal mortality and multiple organ failure during pregnancy. Early prediction of PE can enable timely surveillance and interventions, such as low-dose aspirin administration. In this study, conducted at Stanford Health Care, we examined a cohort of 60 pregnant women and collected 478 urine samples between gestational weeks 8 and 20 for comprehensive metabolomic profiling. By employing liquid chromatography mass spectrometry (LCMS/MS), we identified the structures of seven out of 26 metabolomics biomarkers detected. Utilizing the XGBoost algorithm, we developed a predictive model based on these seven metabolomics biomarkers to identify individuals at risk of developing PE. The performance of the model was evaluated using 10-fold cross-validation, yielding an area under the receiver operating characteristic curve of 0.856. Our findings suggest that measuring urinary metabolomics biomarkers offers a noninvasive approach to assess the risk of PE prior to its onset. |
format | Online Article Text |
id | pubmed-10301596 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103015962023-06-29 Development of a Urine Metabolomics Biomarker-Based Prediction Model for Preeclampsia during Early Pregnancy Zhang, Yaqi Sylvester, Karl G. Jin, Bo Wong, Ronald J. Schilling, James Chou, C. James Han, Zhi Luo, Ruben Y. Tian, Lu Ladella, Subhashini Mo, Lihong Marić, Ivana Blumenfeld, Yair J. Darmstadt, Gary L. Shaw, Gary M. Stevenson, David K. Whitin, John C. Cohen, Harvey J. McElhinney, Doff B. Ling, Xuefeng B. Metabolites Article Preeclampsia (PE) is a condition that poses a significant risk of maternal mortality and multiple organ failure during pregnancy. Early prediction of PE can enable timely surveillance and interventions, such as low-dose aspirin administration. In this study, conducted at Stanford Health Care, we examined a cohort of 60 pregnant women and collected 478 urine samples between gestational weeks 8 and 20 for comprehensive metabolomic profiling. By employing liquid chromatography mass spectrometry (LCMS/MS), we identified the structures of seven out of 26 metabolomics biomarkers detected. Utilizing the XGBoost algorithm, we developed a predictive model based on these seven metabolomics biomarkers to identify individuals at risk of developing PE. The performance of the model was evaluated using 10-fold cross-validation, yielding an area under the receiver operating characteristic curve of 0.856. Our findings suggest that measuring urinary metabolomics biomarkers offers a noninvasive approach to assess the risk of PE prior to its onset. MDPI 2023-05-31 /pmc/articles/PMC10301596/ /pubmed/37367874 http://dx.doi.org/10.3390/metabo13060715 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Zhang, Yaqi Sylvester, Karl G. Jin, Bo Wong, Ronald J. Schilling, James Chou, C. James Han, Zhi Luo, Ruben Y. Tian, Lu Ladella, Subhashini Mo, Lihong Marić, Ivana Blumenfeld, Yair J. Darmstadt, Gary L. Shaw, Gary M. Stevenson, David K. Whitin, John C. Cohen, Harvey J. McElhinney, Doff B. Ling, Xuefeng B. Development of a Urine Metabolomics Biomarker-Based Prediction Model for Preeclampsia during Early Pregnancy |
title | Development of a Urine Metabolomics Biomarker-Based Prediction Model for Preeclampsia during Early Pregnancy |
title_full | Development of a Urine Metabolomics Biomarker-Based Prediction Model for Preeclampsia during Early Pregnancy |
title_fullStr | Development of a Urine Metabolomics Biomarker-Based Prediction Model for Preeclampsia during Early Pregnancy |
title_full_unstemmed | Development of a Urine Metabolomics Biomarker-Based Prediction Model for Preeclampsia during Early Pregnancy |
title_short | Development of a Urine Metabolomics Biomarker-Based Prediction Model for Preeclampsia during Early Pregnancy |
title_sort | development of a urine metabolomics biomarker-based prediction model for preeclampsia during early pregnancy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301596/ https://www.ncbi.nlm.nih.gov/pubmed/37367874 http://dx.doi.org/10.3390/metabo13060715 |
work_keys_str_mv | AT zhangyaqi developmentofaurinemetabolomicsbiomarkerbasedpredictionmodelforpreeclampsiaduringearlypregnancy AT sylvesterkarlg developmentofaurinemetabolomicsbiomarkerbasedpredictionmodelforpreeclampsiaduringearlypregnancy AT jinbo developmentofaurinemetabolomicsbiomarkerbasedpredictionmodelforpreeclampsiaduringearlypregnancy AT wongronaldj developmentofaurinemetabolomicsbiomarkerbasedpredictionmodelforpreeclampsiaduringearlypregnancy AT schillingjames developmentofaurinemetabolomicsbiomarkerbasedpredictionmodelforpreeclampsiaduringearlypregnancy AT choucjames developmentofaurinemetabolomicsbiomarkerbasedpredictionmodelforpreeclampsiaduringearlypregnancy AT hanzhi developmentofaurinemetabolomicsbiomarkerbasedpredictionmodelforpreeclampsiaduringearlypregnancy AT luorubeny developmentofaurinemetabolomicsbiomarkerbasedpredictionmodelforpreeclampsiaduringearlypregnancy AT tianlu developmentofaurinemetabolomicsbiomarkerbasedpredictionmodelforpreeclampsiaduringearlypregnancy AT ladellasubhashini developmentofaurinemetabolomicsbiomarkerbasedpredictionmodelforpreeclampsiaduringearlypregnancy AT molihong developmentofaurinemetabolomicsbiomarkerbasedpredictionmodelforpreeclampsiaduringearlypregnancy AT maricivana developmentofaurinemetabolomicsbiomarkerbasedpredictionmodelforpreeclampsiaduringearlypregnancy AT blumenfeldyairj developmentofaurinemetabolomicsbiomarkerbasedpredictionmodelforpreeclampsiaduringearlypregnancy AT darmstadtgaryl developmentofaurinemetabolomicsbiomarkerbasedpredictionmodelforpreeclampsiaduringearlypregnancy AT shawgarym developmentofaurinemetabolomicsbiomarkerbasedpredictionmodelforpreeclampsiaduringearlypregnancy AT stevensondavidk developmentofaurinemetabolomicsbiomarkerbasedpredictionmodelforpreeclampsiaduringearlypregnancy AT whitinjohnc developmentofaurinemetabolomicsbiomarkerbasedpredictionmodelforpreeclampsiaduringearlypregnancy AT cohenharveyj developmentofaurinemetabolomicsbiomarkerbasedpredictionmodelforpreeclampsiaduringearlypregnancy AT mcelhinneydoffb developmentofaurinemetabolomicsbiomarkerbasedpredictionmodelforpreeclampsiaduringearlypregnancy AT lingxuefengb developmentofaurinemetabolomicsbiomarkerbasedpredictionmodelforpreeclampsiaduringearlypregnancy |